[1
]Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA,
United Kingdom;
[2
]Cytogenetics Facility, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA,
United Kingdom;
[3
]Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom;
[4
]Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
[5
]Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge
CB2 0RE, United Kingdom;
[6
]BioCare, Strategic Cancer Research Program, SE-223 81 Lund, Sweden;
[7
]CREATE Health, Strategic Centre for Translational Cancer Research, SE-221 00 Lund,
Sweden;
[8
]Department of Oncology and Pathology, Lund University Cancer Center, SE-221 85 Lund,
Sweden;
[9
]Breakthrough Breast Cancer Research Unit, Research Oncology, King's College London,
Guy's Hospital, London SE1 9RT, United Kingdom;
[10
]Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative
Medical Sciences, 230-0045 Yokohama, Japan;
[11
]National Center for Genome Medicine, Institute of Biomedical Sciences, Academia Sinica,
Taipei 115, Taiwan;
[12
]Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center,
University of California, San Francisco, California 94158, USA;
[13
]Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands;
[14
]Department of General Surgery, Singapore General Hospital, Singapore 169608;
[15
]Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver V5Z 1L3,
Canada;
[16
]Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University
Medical Center, 6525 HP Nijmegen, Netherlands;
[17
]Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical
Center, 3015 CE Rotterdam, Netherlands;
[18
]Section of Oncology, Department of Clinical Science, University of Bergen, N-5020
Bergen, Norway;
[19
]Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway;
[20
]Institut Curie, INSERM U934 and Department of Tumor Biology, 75248 Paris cédex 05,
France;
[21
]Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The
Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway;
[22
]The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine,
Faculty of Medicine, University of Oslo, 0450 Oslo, Norway;
[23
]Cancer Research Laboratory, University of Iceland, 101 Reykjavik, Iceland;
[24
]Royal National Orthopaedic Hospital, Middlesex HA7 4LP, United Kingdom;
[25
]UCL Cancer Institute, University College London, London WC1E 6DD, United Kingdom;
[26
]University of Liverpool and HCA Pathology Laboratories, London WC1E 6JA, United Kingdom;
[27
]Urological Research Laboratory, Cancer Research UK Cambridge Research Institute, Cambridge
CB2 0RE, United Kingdom;
[28
]Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital,
Cambridge CB2 0QQ, United Kingdom;
[29
]Institute of Cancer Research, Sutton, London SM2 5NG, United Kingdom;
[30
]Department of Biological Sciences and School of Medicine, University of East Anglia,
Norwich NR4 7TJ, United Kingdom;
[31
]Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton SM2
5NG, United Kingdom;
[32
]Royal Marsden NHS Foundation Trust, London SW3 6JJ and Sutton SM2 5PT, United Kingdom;
[33
]University of Queensland, School of Medicine, Brisbane, QLD 4006, Australia;
[34
]Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia;
[35
]University of Queensland, UQ Centre for Clinical Research, Brisbane, QLD 4029, Australia;
[36
]Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut
Jules Bordet, 1000 Brussels, Belgium;
[37
]Université Lyon 1, Institut National du Cancer (INCa)–Synergie, 69008 Lyon, France;
[38
]Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
[39
]Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115,
USA;
[40
]Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United
Kingdom;
[41
]Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston,
Texas 77030, USA
License:
This article, published in
Genome Research, is available under a Creative Commons License (Attribution 4.0 International), as
described at
http://creativecommons.org/licenses/by/4.0/.
